Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 2/20 | 0.39 |
| ▸ | MMP12 | P39900 | 2/20 | 0.39 |
| ▸ | MMP13 | P45452 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1365530 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL2206774 | 0.89 | TAAR1 (0.40) | MMP8MMP12MMP13ALDH1A1HTT | |
| SCHEMBL7865730 | 0.81 | TAAR1 (0.44) | — | |
| SCHEMBL8671567 | 0.81 | MMP8 (0.46) | MMP8MMP12MMP13ALDH1A1HTT | |
| SCHEMBL22558665 | 0.78 | MMP8 (0.42) | MMP8MMP12MMP13ALDH1A1HTT | |
| SCHEMBL5543296 | 0.78 | MMP8 (0.39) | MMP8MMP12MMP13ALDH1A1HTT | |
| SCHEMBL25080869 | 0.77 | HTT (0.42) | MMP8MMP12MMP13ALDH1A1HTT | |
| SCHEMBL5540521 | 0.77 | MMP8 (0.38) | MMP8MMP12MMP13ALDH1A1HTT | |
| SCHEMBL27260021 | 0.77 | MMP8 (0.38) | MMP8MMP12MMP13ALDH1A1HTT | |
| SCHEMBL27259499 | 0.77 | MMP8 (0.38) | MMP8MMP12MMP13ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758897-B1 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | AVENTIS PHARM PROD INC (US) | 2004-02-25 | — | — | EP | disclosed |
| US-6392049-B1 | NITRATION USING NITRIC ACID | AVENTIS PHARMACEUTICALS INC. | 2002-05-21 | — | — | US | disclosed |
| US-6307054-B1 | HEATING A 5-CARBOXY-2,4-DIHYROXYPYRIDINE AND PHOSPHORIC ACID WHERE THE RATIO OF PHOSPHORIC ACID TO WATER IS NOT LESS THAN ABOUT 27 TO 1 WEIGHT %. | AVENTIS PHARMACEUTICALS PRODUCTS INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1006115-A2 | Imidazopyridines having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 2000-06-07 | — | — | EP | disclosed |
| EP-0909270-A4 | — | — | 1999-04-21 | — | — | EP | disclosed |
| EP-0909270-A1 | PROCESS FOR PREPARING 2,4-DIHYDROXYPYRIDINE AND 2,4-DIHYDROXY-3-NITROPYRIDINE | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-04-21 | — | — | EP | disclosed |
| US-5736554-A | TREATING AND/OR PREVENTING CARDIOVASCULAR DISORDERS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-04-07 | — | — | US | disclosed |
| EP-0758897-A4 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | RHONE POULENC RORER PHARMA (US) | 1997-11-19 | — | — | EP | disclosed |
| US-5652366-A | ADENOSINE AGONISTS; HYPOTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTILIPOLYTIC AGENTS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-29 | — | — | US | disclosed |
| WO-1997024327-A1 | PROCESS FOR PREPARING 2,4-DIHYDROXYPYRIDINE AND 2,4-DIHYDROXY-3-NITROPYRIDINE | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-10 | — | — | WO | disclosed |
| EP-0758897-A1 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1997-02-26 | — | — | EP | disclosed |
| US-5561134-A | ADENOSINE DERIVATIVES | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-10-01 | — | — | US | disclosed |
| WO-1995028160-A1 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1995-10-26 | — | — | WO | disclosed |
| US-5364862-A | Adenosine derivatives | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-11-15 | — | — | US | disclosed |